Financial Results for the First Quarter of Fiscal Year Ending March 31, 2012
July 28, 2011
Exchange where listed: TSE

Name of listed company: TERUMO CORPORATION(URL http://www.terumo.com/): 4543: Yutaro Shintaku, Representative Director and President: Tetsuya Kumei, General Manager, Corporate Communication Dept.
: +81 / 3-3217 -6550

Company code number
Representative:
Please address all communications toPhone

1. Consolidated financial highlights for the interim period ended June 2011
(From April 1, 2011 to June 30, 2011)(1) Consolidated financial results(Note: The amounts shown below ignore values of less than a million yen)

Net sales

Operating income(Millions of yen)Three months ended June, 2011
Three months ended June, 2010
(Notes) Comprehensive income:%

95,63081,234(Millions of yen)%

17,37815,946

17.7
4.9

June 2011: 5,914million yen ( －%)Ordinary income(Millions of yen)

16,86812,5549.0(3.2)

Net income%(Millions of yen)

9,772
8,792

34.4
(25.9)%

11.1(18.7)

June 2010: （2,292）million yen (－%)

Net income per share

Net income per share,
fully diluted(Yen)

(Yen)

－
51.46
Three months ended June, 2011
46.30－
Three months ended June, 2010
(Note) Percentage represent increase (decrease) from the corresponding period in the prior fiscal year.

(2) Consolidated financial position(Note: The amounts shown below ignore values of less than a million yen)

Total assets

As at June 30, 2011
As at March 31, 2011

Equity ratio

Net assets

Net assets per share(Millions of yen)

(Millions of yen)%(Yen)

693,587
420,037

337,950
335,45648.7
79.8

1,778.47
1,765.32(Note) Shareholders' equity : June 30, 2011: 337,696 million yen, March 31, 2011: 335,202 million yen.

2. Dividends

1st quarter

Cash dividends per share
2nd quarter 3rd quarter 4th quarter

total

(Yen)

(Yen)

(Yen)

(Yen)

(Yen)

－－

16.00

－

18.00

34.00

17.00

－

17.00

34.00

Year ended March 31, 2011
Year ending March 31, 2012
Year ending March 31, 2012 (forecast)(Note) Revise of dividends forecast : None

3. Consolidated forecast for the year ending March 2012 (From April 1, 2011 to March 31, 2012)
Operating income

Net sales

Half year ending September, 2011
Year ending March, 2012

Net income
per share

Net income

Ordinary income(Millions of yen)%

(Millions of yen)%

(Millions of yen)%

(Millions of yen)%

191,000
390,000

16.5
18.8

32,70067,0000.0
7.0

31,50065,00011.8
14.2

18,50038,500

0.7
19.1

(Yen)

97.43
202.76

1. Forecast for fiscal year ending March, 2012 which was announced on May 11, 2011 has been revised.
(Assumed exchange rate for fiscal year ending March, 2012: USD1=JPY80, EUR1=JPY113)
2. Among the information that Terumo discloses, forecasts of financial performance on future projections contain potential risks and uncertainty since these areforecasts on projections made by Terumo based on limited information available at the moment of disclosure. Accordingly, it should be noted that actual results
may differ from those forecasts on projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic
conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.

4. Changes in significant subsidiaries during the interim period
New 3 companies: CaridianBCT Holding Corp., CaridianBCT Inc., Gambro, Inc.

15. Consolidated Financial Statements(1) Consolidated Balance Sheets(Millions of yen)
As at March 31, 2011
Amount(Assets)
I Current assets

236,510%56.3%

As at June 30, 2011
Amount%251,025

Cash and deposits

83,794

83,295

Notes and accounts receivable-trade

76,48084,125Inventries

57,67366,043

Deferred tax assets

7,797

10,510Derivatives

6,084－Other

5,406

7,997

Allowance for doubtful accounts

(726)

(946)

36.2%

II Noncurrent assets

183,52743.7%

442,56163.8%

1. Property, plant and equipment

113,05926.9%

125,428

18.1%

Buildings and structures

45,05247,742

Machinery, equipment and vehicles

29,861

34,959Land

20,227

21,279950

1,097

Construction in progress

10,442

13,464

Other

6,524

6,884

Lease assets

2. Intangible assets

26,728Goodwill

20,191

6.4%

141,579

Other

6,537

131,920

3. Investments and other assets

43,739Investment securities

28,89531,452

Deferred tax assets

8,136

6,375

Other

6,706

5,806

Total assets

420,0372

10.4%

273,499

100.0%

43,634

693,587

39.4%

6.3%

100.0%

(Millions of yen)As at March 31, 2011
Amount(Liabilities)
I Current liabilities%

78,846

Notes and accounts payable-trade18.8%

As at June 30, 2011
Amount%302,626

30,71132,197－220,000

294

322

Income taxes payable

6,297

5,045

Deferred tax liabilities

123

138

Provision for bonuses

Short-term loans payable
Lease obligations

5,001

2,681

Provision for directors' bonuses

145

36

Provision for loss on disaster

351

138

5,749

7,495

560

980

Notes and accounts payable - facilities
Asset retirement obligations
Other

29,611

33,590II Noncurrent liabilities5,734

Lease obligations

636

752

Deferred tax liabilities

378

45,474

1,082
586

1,146
202

991

571

2,060

4,862

Provision for retirement benefits
Provision for directors' retirement benefits
Asset retirement obligations
Other

Total liabilities(Net assets)
I Shareholders' equity

1.3%

53,01020.1%

355,63751.3%

363,83286.6%

370,184

53.4%

38,716

38,716

Capital surplus

59,03059,030Retained earnings

342,965

349,319

Treasury stock(76,879)(76,882)(28,630)(6.8%)(32,487)

Valuation difference on available-for-sale securities(1,919)263

Deferred gains or losses on hedges

3,611

(0)

Foreign currency translation adjustment(30,322)254

III Minority interests
Total net assets
Total liabilities and net assets

3

7.7%

84,581

Capital stock

II Accumulated other comprehensive income

43.6%(4.7%)

0.1%(32,749)253

335,45679.9%

337,95048.7%

420,037

100.0%

693,587

100.0%

0.0%

(2) Consolidated Statements of Income(Millions of yen)

For three months ended
June 30, 2011
AmountI Net sales
II Cost of sales
Gross profit
III Selling, general and administrative expenses
Operating income
IV Non-operating income%For three months ended
June 30, 2010
Amount%95,630100.0%

81,234100.0%

44,78746.8%

38,89847.9%

50,842
33,463

53.2%
35.0%

42,336
26,389

52.1%
32.5%

17,37818.2%

15,946

19.6%

367

0.5%

Interest income

8667

Dividends income

154

150

Royalty income

3738

Equity in earnings of affiliates

33

34

Other91

402

0.4%

76

V Non-operating expenses
Interest expenses

161

28

Sales discounts

146

Foreign exchange losses

451

144
3,439

Loss on disposal of inventories

5335

Other

99

Ordinary income
VI Extraordinary income
Gain on sales of noncurrent assets
Reversal of allowance for doubtful accounts

913

1.0%

16,868

17.6%

111

122－
156

0－

Gain on contribution of securities to retirement
benefit trust－

494

Subsidy income

227

Reversal of provision for loss on disaster

395

0.4%

－

3,759

4.6%

12,554

15.5%

497

0.6%

190.1%

13,031

16.0%

4,219

5.2%

8,812
19
8,792

10.8%
0.0%
10.8%

VII Extraordinary expenses
Loss on disposal of noncurrent assets

4

Loss on valuation of investment securities

31,112

Directors' retirement benefit－

Income before income taxes
Income taxes-current

5,751

Income taxes-deferred

613

Income before minority interests
Minority interests income

Net income

4

1,116

1.1%

16,147

16.9%

6,365

6.7%

9,781
9
9,772

10.2%
0.0%
10.2%

－
15
2,666
1,552

(3) Consolidated statement of comprehensive income(Millions of yen)

For three months ended
June 30, 2011
AmountI Income before minority interests
II Other comprehensive income
securities

%
9,781

For three months ended
June 30, 2010
Amount100.0%8,812

Valuation difference on available-for-sale securities

2,183(4,699)Deferred gains or losses on hedges
Foreign currency translation adjustments
Share of other comprehensive income of associates
accounted for using equity method(3,612)(2,437)－(6,404)(0)Comprehensive income%(1)

100.0%(3,867)(39.5%)(11,105) (126.0%)

5,914

60.5%

(2,292)(26.0%)

5,914

60.5%
(0.0%)(2,288)(26.0%)(3)(0.0%)

Attributable to:Shareholders of Terumo Corporation
Minority interests(0)5

6. Segment Information[Reportable Segments](1) The First Quarter of Fiscal Year Ended March 31, 2011

GeneralHospitalbusiness

For three months ended
June 30, 2011

Cardiac &Vascularbusiness

Blood
Transfusionbusiness

Consumer
Healthcare
business

Subtotal

Adjustment

Total

Sales and operating income:Sales to customer

37,07736,4476,443

802

80,771463-------

Sales total

37,07736,4476,443

802

80,771

463

81,234

Segment income (loss)

6,337
9,598
813
(373)
16,375(429)
15,946
1. The (429) million yen adjustment to segment profit is the sum of the (506)Internal sales

Notes:

81,234

million yen for Inventories and the 77 million yen for others.
2. Segment profit is adjusted to be consistent with operating income shown on thequarterly consolidated income statement.
(2) The First Quarter of Fiscal Year Ending March 31, 2012
For three months ended
June 30, 2012

Blood
Managementbusiness

Cardiac &Vascularbusiness

GeneralHospitalbusiness

Consumer
Healthcare
business

Subtotal

Adjustment

Total

Sales and operating income:Sales to customer

36,49939,95518,042

1,133

95,630--------

Sales total

36,49939,95518,0421,133

95,630-95,630

Segment income (loss)

7,877
9,629
1,561(63)19,004(1,625)
17,378
1. The (1,625) million yen adjustment to segment profit is the sum of the (2,712)

Internal sales

Notes:

95,630

million yen for Inventories and the 1,086 million yen for others.
2. Segment profit is adjusted to be consistent with operating income shown on thequarterly consolidated income statement.
3. From the first quarter of fiscal year ending March 31, 2012, the name ofreportable segment has been changed from Blood Transfusion business to BloodManagement business.
(Additional Information)
From this first quarter, Caridian BCT Holding Corp. is newly added to Terumo group as a consolidating subsidiary withan acquisition of 100% of its shares.
As a unit of reportable segments, the business of BCT is classified as Blood Transfusion business.
From this effect, goodwill has increased by 124,427 million yen for the first quarter of fiscal year ending March, 31,
2012.
(Note) Main products belonging to each business segment

Business segments

Main products

General Hospital business
Disposable medical devices
and Medical electronics

Syringes, Needles, Blood collection tubes, Home parenteral nutrition system,
Solution sets, I.V.catheters, Infusion pumps, Syringe pumps, Home oxygen therapysystem, etc.

Pharmaceuticals

I.V.solutions, Nutritious food, Prefilled syringes, CAPD systems, etc.

Diabetes care products

Blood glucose monitoring systems

Cardiac and Vascular business
Interventional systems

Angiographic catheters, PTCA balloon catheters, Coronary stents, Neuro interventionalcoils, etc.

Cardiovascular systems

Oxygenerators, Cardio-pulmonary bypass system, LVA system, etc.

Vascular grafts

Artificial vascular grafts, Stent grafts

Blood Management business

Blood bags, Automated blood processing, Therapeutic aphaeresis, Cell therapy, etc.

Consumer Healthcare business

Digital thermometers, Blood pressure monitors, Blood glucose monitors (OTC), etc.

6

(Supplemetary Information)[Geographic segments](1) Three month ended June 30, 2010

(Millions of yen)
For three months ended
June 30, 2010

JapanEuropeAmericas

ChinaAsia and others

TotalSales

42,545

13,78815,782

2,125

6,992

81,234

Operating income

8,843

2,676

2,227

644

1,555

15,946(2) Fiscal year ended June 30, 2011

(Millions of yen)
For three months ended
June 30, 2011JapanEurope

Americas

China

Asia and others

Total

Sales

44,27615,03526,852

2,409

7,056

95,630Operating income

9,326

2,683

3,745

654

967

17,3787